Sandoz receives positive CHMP opinion for citrate-free high concentration formulation of adalimumab biosimilar Read more
Dupixent (dupilumab) approved by European Commission as the first and only targeted medicine indicated for eosinophilic esophagitis Read more
Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease Read more
Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor Read more
European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer’s disease: BioArctic Read more
CytomX Therapeutics Announces Milestone Achievement in Probody T-Cell Engaging Bispecific (TCB) Collaboration with Astellas Read more